Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (20480)	5/11/1998 5:18:00 PM
From: HerbertOtto	Read Replies (1) \| Respond to of 32384

LGND gets another Cancer candidate! Looks hot! Management is learning to get into the action quickly. Especially nice is that $30M is contigent on the FDA approval of the new Cancer drug, and the review panel meets on 6-2-98. Talk about 'something happening'! We also have in the wind the NDA for Panretin Gel by the end of May. That is nearly upon us. With quarterly report due out this Thursday 5-14, it looks like there are many positive news bits to choose from to accompany the report. It 'should be a good month' indeed! Good luck, Herbert